|
Suvratoxumab
|
DB15172 |
[Suvratoxumab is under investigation in clinical trial NCT02296320 (Study of the Efficacy and Safety of MEDI4893).] |
|
4-Methoxy-E-Rhodomycin T
|
DB03199 |
|
|
RU81843
|
DB04495 |
|
|
6-amino-1-methyl-7H-purin-1-ium
|
DB03164 |
|
|
2-Dimethylamino-Ethyl-Diphosphate
|
DB03165 |
|
|
4-Phospho-D-Erythronohydroxamic Acid
|
DB04496 |
|
|
Fructose-6-Phosphate
|
DB04493 |
|
|
4-oxo-4,5-dihydro-1,2,5-thiadiazole-3-carboxylic acid
|
DB03162 |
|
|
2-oxopropyl-CoM
|
DB03163 |
|
|
Dihydroxy(oxo)molybdenum(6+)
|
DB04494 |
|
|
Diisopropylphosphono Group
|
DB04491 |
|
|
N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate
|
DB03160 |
|
|
Thymidine-5'-diphospho-beta-D-xylose
|
DB03161 |
|
|
2-(acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose
|
DB04492 |
|
|
3-(Mercaptomethylene)Pyridine
|
DB04490 |
|
|
Futibatinib
|
DB15149 |
[Futibatinib is under investigation in clinical trial NCT02052778 (A Study of TAS-120 in Patients With Advanced Solid Tumors).] |
|
Adrabetadex
|
DB15146 |
[Adrabetadex is under investigation in clinical trial NCT03887533 (Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1).] |
|
Ziresovir
|
DB15145 |
[Ziresovir is under investigation in clinical trial NCT03699202 (Anti-RSV Study in Chinese Patients (ASCENT)).] |
|
Lenzilumab
|
DB15148 |
[Lenzilumab is under investigation in clinical trial NCT02546284 (Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)).] |
|
Tinostamustine
|
DB15147 |
[Tinostamustine is under investigation in clinical trial NCT03452930 (Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma).] |
